# A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old

> **NCT06944717** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Vaxart** · enrollment: 60 (estimated)

## Conditions studied

- Norovirus Infections

## Interventions

- **BIOLOGICAL:** VXA-G1.1-NN
- **BIOLOGICAL:** VXA-G2.4-NS
- **BIOLOGICAL:** VXA G1.1 NN-T
- **BIOLOGICAL:** VXA G2.4 NS-T

## Key facts

- **NCT ID:** NCT06944717
- **Lead sponsor:** Vaxart
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-03
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06944717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06944717, "A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06944717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*